1985 Volume 33 Issue Supplement5 Pages 221-224
HAPA-B is a new aminoglycoside derivative with broad antibacterial spectrum (Gram positive bacteria, Gram negative bacteria).
HAPA-B was administered intramuscularly to 10 patients (pneumonia 4 cases, acute bronchitis 1 case, tonsillitis 1 case, acute pyelonephritis 4 cases) at daily dose of 400mg and good response were obtained in all cases (100%). HAPA-B was effective in 2 cases with Staphylococcal infection.
Eosinophilia was noted in 1 case. One case demonstrated a transient elevation of serum transaminase levels.